Safeguarding the Global Supply of Medicines
Eroding Patient Confidence in Biologic Medicines
Safeguarding the Global Supply of Medicines
Eroding Patient Confidence in Biologic Medicines
previousnext

How Generics Increased Access to Treatment and Lowered Drug Costs

Impact of Generics

Over the past three decades, generic medicines have significantly increased patient access to quality treatment, while lowering healthcare costs in the United States. Learn how a new class of prescription drugs knows as biosimilars, offers the same hope of increased access and reduced costs.

Share

Trust in Public Health Crumbles Without Quality

Trust in Public Health

The 69th World Health Assembly, took place in Geneva on May 23 – 28, 2016, and USP was honored to co-host a high level discussion on global public health and the SDGs (Sustainable Development Goals). This article captures parts of the conversation that took place not only in Geneva but via social media as well.

Share

Pharmaceutical Manufacturing in LMICs: Where Things Go Wrong

Root Causes of Substandard Medicines

In LMICs, the availability of medicines manufactured locally that do not meet quality standards is a leading cause of treatment failure and adverse events in patients and is undermining public health interventions. But where do things go wrong during pharmaceutical manufacturing in LMICs that give rise to this problem? Learn more.

Share

Pages

Related Stories

Letter to Senate on Biologics Quality
Industry, payers & pharmacy groups support USP in opposing removal of quality standard requirement for biologics.
USP Standards for Plastic Packaging Systems for Drugs
USP Q&A: Standards for Plastic Packaging Systems for Drug Products
CePAT Opens New Microbiology Lab in Africa
CePAT Opens New Microbiology Lab, a ‘Game-Changer’ in Africa
New Standards for Handling Hazardous Drugs Help Protect Personnel & Patients
Handling Hazardous Drugs Is about Protecting Healthcare Personnel and Patients
What the Letters "USP" Mean on the Label of Your Medicine